Advanced search

Burkhart Grund occupies the position of Group Chief Finance Officer & Executive Director at Compagnie Financière Richemont SA. In the past he was Chief Financial Officer of Montblanc France SASU, Chief Financial Officer & Vice President for Van Cleef & Arpels SA and Chief Financial Officer for Procter & Gamble Deutschland GmbH. He received an undergraduate degree from Georgia Southern University and an undergraduate degree from the University of Münster.

Curtis B.
Grund worked as a Vice President at ORC Worldwide, Inc.

Vlado Grund served as a Member-Supervisory Board at Koncar-Distributivni.
I Specijalni Transformatori dd from 2015 to 2019.

Nicholas Grund is currently the Chief Commercial Officer at Akebia Therapeutics, Inc. He previously held positions as the Head-Specialty Care at Genzyme Corp from 2007 to 2015, the Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2016 to 2019, and as the President-Eurofins at Transplant Genomics, Inc. from 2021 to 2022.
Mr. Grund also worked as a Principal at Bayer Diagnostics Corp.
from 1995 to 2002.
He holds an MBA from Northeastern University and an undergraduate degree from the University of Massachusetts.

Ines Grund is currently a Director at Thames Water Ltd., Southern Gas Networks Plc, Scotland Gas Networks Plc, Mapleco1 Ltd., SGN Midco Ltd., SGN PledgeCo Ltd., and SGN Place Ltd.
He previously worked as a Director at Scotia Gas Networks Ltd., Kemble Water Holdings Ltd., and Maple TopCo Ltd.